Skip to main content
# Title Department Research Member Research Year
61 Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2022
62 Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations Department of Anesthesia, Intensive care and Pain management Dr. Neveen Abdelazeem Abdelraheem 2022
63 Total-Body 18F-FDG PET/CT in Autoimmune Inflammatory Arthritis at Ultra-Low Dose: Initial Observations Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2022
64 Malnutrition Assessment in Pediatric Acute Lymphoblastic Leukemia in Upper Egypt and Its Effect on Induction Response Department of Pediatric Oncology Sarah Nour El-dien Obaid Maher 2022
65 Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2022
66 Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Prof. Khaled Mohamed Fares Ali 2022
67 Efficacy of Ketamine versus Magnesium Sulphate as Adjuvants to Levobupivacaine in Ultrasound Bilevel Erector Spinae Block in Breast Cancer Surgery (a Double-Blinded Randomized … Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2022
68 Pharmacokinetics and Pharmacodynamics of Dexmedetomidine Administered as an Adjunct to Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Ahmed Hassan Othman Hassan 2022
69 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Department of Clinical Pathology maureen raafat 2022
70 Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2022